EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)Randomisierte kontrollierte StudieOpen Access

Clinical Pharmacists, Medications, and Contingency Management for Targeting Smoking in HIV Clinics

E Jennifer Edelman, Yanhong Deng, James Dziura, Inbal Nahum-Shani, June-Marie Weiss, Lydia Aoun-Barakat, Krysten W Bold, Dini Harsono, Colleen Mistler, Erika Payne, Sherry Aiudi, Keith M Sigel und 3 weitere

JAMA Network Open · 2026

DOI: 10.1001/jamanetworkopen.2025.60593 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift JAMA Network Open, 2026. Verfasst von E Jennifer Edelman und 14 weiteren Autor:innen. Beteiligte Einrichtung: Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut. Hauptthemen laut MEDLINE: HIV Infections, Pharmacists, Smoking Cessation, Tobacco Use Disorder. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDA NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance There is a lack of robust strategies to reduce cigarette smoking among people with HIV.

Objective

To identify optimal adaptive treatment strategies involving clinical pharmacist–delivered medications for tobacco use disorder and contingency management (CM) for smoking reduction among people with HIV. Design, Setting, and Participants From July 27, 2020, through March 28, 2024, using a sequential multiple-assignment randomized clinical trial, people with HIV who smoked cigarettes were recruited and randomized 1:1 to nicotine replacement therapy (NRT) with or without CM (stage 1). After 12 weeks of treatment (stage 2), individuals with confirmed abstinence continued stage 1 treatment; individuals without confirmed abstinence were rerandomized to switch to oral medications for tobacco use disorder or to intensified CM. Interventions were delivered by clinical pharmacists in HIV clinics across 24 weeks.

Interventions

Stage 1 included NRT with or without CM (rewards for confirmed abstinence). Stage 2 included either a switch to varenicline or bupropion or intensification to more rewards for abstinence. Each stage involved 5 clinical pharmacist visits. Main Outcomes and Measures The primary outcome was cigarettes per day (CPD), and the secondary outcome was 7-day confirmed abstinence at 12 and 24 weeks with imputation. Analyses were conducted using intention-to-treat principles.

Results

In total, 323 participants (181 [56.0%] male at birth; 317 [72.5%] Black or African American; mean [SD] age, 55.1 [10.7] years) smoked a mean (SD) of 12.8 (7.2) CPD at baseline. At 12 weeks, participants in the NRT plus CM (least-squares mean [LSM], 4.9 [97.5% CI, 3.5-6.2] CPD) and NRT (LSM, 5.2 [97.5% CI, 3.9-6.5] CPD) groups smoked similar numbers of CPD (adjusted LSM difference, −0.3 [97.5% CI, −1.9 to 1.3]; P = .66). Abstinence was greater at 12 weeks in the NRT plus CM group (36 of 160 [22.5%]) compared with the NRT group (16 of 163 [9.8%]) (adjusted odds ratio [AOR], 2.70 [99.0% CI, 1.19-6.14]; P = .002). Among participants without week 12 abstinence, the effect of intensifying vs switching on week 24 CPD varied by stage 1 treatment. Intensifying was better among individuals starting with NRT alone (adjusted LSM difference, −3.8 [97.5% CI, −6.0 to −1.5] CPD; P < .001) but not among individuals initially receiving NRT plus CM (adjusted LSM difference, 0.3 [97.5% CI, −2.1 to 2.6] CPD; P = .80). Abstinence at 24 weeks was similar among individuals in intensified vs switched groups regardless of stage 1 treatment (AOR, 1.5 [99% CI, 0.4-4.2]; P = .37; P = .85 for interaction). Overall, 24-week CPD was lowest with the adaptive treatment strategy involving NRT followed by NRT plus CM (eg, LSM, 2.6 [99% CI, 1.1-4.1] CPD vs 4.2 [99% CI, 2.6-5.9] CPD for NRT plus CM followed by NRT plus CM intensified), and abstinence was highest for the NRT plus CM followed by the intensified strategy (eg, LSM, 30.0% [99% CI, 16.2%-48.7%] vs 12.8% [99% CI, 5.2%-28.3%] for NRT followed by NRT plus CM intensified). Conclusions and Relevance In this randomized clinical trial of people with HIV who smoked cigarettes, CM was an effective adjunct to clinical pharmacist–delivered NRT for improving tobacco-related outcomes. Optimal timing to add CM differed based on treatment goals. Trial Registration ClinicalTrials.gov Identifier: NCT04490057

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsPharmacistsSmoking CessationTobacco Use DisorderAdultFemaleHumansMaleMiddle AgedAdherence InterventionsBupropionNicotine Replacement TherapyVarenicline

Substanzen

BupropionVarenicline

Autor:innen und Institutionen

  • Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut.
  • Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
  • Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, Connecticut.
  • Yale Center for Analytic Sciences, Yale School of Public Health, New Haven, Connecticut.
  • Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut.
  • Department of Psychiatry, Medical School and Data-science for Dynamic Decision-making Center (d3c), Institute For Social Research, University of Michigan, Ann Arbor.

Förderung

  • NCI NIH HHS
  • NIDA NIH HHS
  • NIMH NIH HHS

Zitieren

APA

Edelman, E. J., Deng, Y., Dziura, J., Nahum-Shani, I., Weiss, J. M., Aoun-Barakat, L., Bold, K. W., Harsono, D., Mistler, C., Payne, E., Aiudi, S., Sigel, K. M., Yager, J. E., Ledgerwood, D. M., & Bernstein, S. L. (2026). Clinical Pharmacists, Medications, and Contingency Management for Targeting Smoking in HIV Clinics. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.60593

Vancouver

Edelman EJ, Deng Y, Dziura J, Nahum-Shani I, Weiss JM, Aoun-Barakat L, et al. Clinical Pharmacists, Medications, and Contingency Management for Targeting Smoking in HIV Clinics. JAMA Network Open. 2026. doi:10.1001/jamanetworkopen.2025.60593

BibTeX
@article{Edelman2026,
  author = {Edelman, E Jennifer and Deng, Yanhong and Dziura, James and Nahum-Shani, Inbal and Weiss, June-Marie and Aoun-Barakat, Lydia and Bold, Krysten W and Harsono, Dini and Mistler, Colleen and Payne, Erika and Aiudi, Sherry and Sigel, Keith M and Yager, Jessica E and Ledgerwood, David M and Bernstein, Steven L},
  title = {Clinical Pharmacists, Medications, and Contingency Management for Targeting Smoking in HIV Clinics},
  journal = {JAMA Network Open},
  year = {2026},
  doi = {10.1001/jamanetworkopen.2025.60593}
}
Kostenlos starten →